Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnarajah Nirantharakumar

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 9, 2021
Association of Metformin with Susceptibility to COVID-19 in People with Type 2 DiabetesJingya Wang, Jennifer M Cooper, Krishna Gokhale, et al.
BMC Pregnancy and Childbirth|February 12, 2022
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional studySiang Ing Lee, Amaya Azcoaga-Lorenzo, Utkarsh Agrawal, et al.
BMC Medicine|January 16, 2023
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019Anuradhaa Subramanian, Amaya Azcoaga-Lorenzo, Astha Anand, et al.
Cardiovascular Diabetology|August 31, 2023
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and AsiaDorte Vistisen, Bendix Carstensen, Patorno Elisabetta, et al.
BMJ Open|February 24, 2023
Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UKSiang Ing Lee, Holly Hope, Dermot O'Reilly, et al.
BMJ Open|October 9, 2023
Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocolAnuradhaa Subramanian, Siang Ing Lee, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, et al.
Diabetes & Metabolism|January 7, 2023
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) studyAvraham Karasik, Stefanie Lanzinger, Elise Chia-Hui Tan, et al.
BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
BMC Medicine|August 22, 2023
The development of a core outcome set for studies of pregnant women with multimorbiditySiang Ing Lee, Stephanie Hanley, Zoe Vowles, et al.
Nature Medicine|July 25, 2022
Symptoms and risk factors for long COVID in non-hospitalized adultsAnuradhaa Subramanian, Krishnarajah Nirantharakumar, Sarah Hughes, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Endocrinology and Metabolism|February 9, 2021
Association of Metformin with Susceptibility to COVID-19 in People with Type 2 DiabetesJingya Wang, Jennifer M Cooper, Krishna Gokhale, et al.
BMC Pregnancy and Childbirth|February 12, 2022
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional studySiang Ing Lee, Amaya Azcoaga-Lorenzo, Utkarsh Agrawal, et al.
BMC Medicine|January 16, 2023
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019Anuradhaa Subramanian, Amaya Azcoaga-Lorenzo, Astha Anand, et al.
Cardiovascular Diabetology|August 31, 2023
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and AsiaDorte Vistisen, Bendix Carstensen, Patorno Elisabetta, et al.
BMJ Open|February 24, 2023
Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UKSiang Ing Lee, Holly Hope, Dermot O'Reilly, et al.
BMJ Open|October 9, 2023
Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocolAnuradhaa Subramanian, Siang Ing Lee, Sudasing Pathirannehelage Buddhika Hemali Sudasinghe, et al.
Diabetes & Metabolism|January 7, 2023
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) studyAvraham Karasik, Stefanie Lanzinger, Elise Chia-Hui Tan, et al.
BMC Medical Informatics and Decision Making|October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisionsAlvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
BMC Medicine|August 22, 2023
The development of a core outcome set for studies of pregnant women with multimorbiditySiang Ing Lee, Stephanie Hanley, Zoe Vowles, et al.
Nature Medicine|July 25, 2022
Symptoms and risk factors for long COVID in non-hospitalized adultsAnuradhaa Subramanian, Krishnarajah Nirantharakumar, Sarah Hughes, et al.
Pageof 27